GlassScriptPhysician profile
Timothy Vellinga
NPI 1336109198
$2,536.04
in general payments reported to CMS, 2019-2025
12 companies · $203 in 2025
The $203 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2020: $214 · 2021: $308 · 2022: $402 · 2023: $569 · 2024: $703 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,475.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,010.78 | 2019-2024 | Optis, Ultreon, Assurity |
| Abiomed | $488.62 | 2021-2025 | Impella |
| Shockwave Medical, INC | $435.80 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Cvrx, INC. | $221.82 | 2022-2023 | Barostim Neo System |
| Boston Scientific Corporation | $102.98 | 2021-2023 | Avvigo Guidance System |
| Chiesi USA, INC. | $89.29 | 2021-2024 | Kengreal, Cleviprex |
| E.R. Squibb & Sons, L.L.C. | $66.27 | 2021-2024 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $44.69 | 2021-2022 | |
| Medtronic Vascular, INC. | $28.67 | 2019-2020 | |
| Medtronic, INC. | $20.16 | 2023 | Onyx Frontier |
| Baxter Healthcare | $18.68 | 2025 | Perclot |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $8.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Vellinga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.